Nuwellis (NUWE) Competitors $0.31 -0.06 (-15.99%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. MHUA, WOK, ICU, BTCY, DHAI, INBS, PAVM, SSKN, LUCY, and CODXShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Meihua International Medical Technologies (MHUA), WORK Medical Technology Group LTD Ordinary Shares (WOK), SeaStar Medical (ICU), Biotricity (BTCY), DIH Holding US (DHAI), Intelligent Bio Solutions (INBS), PAVmed (PAVM), STRATA Skin Sciences (SSKN), Innovative Eyewear (LUCY), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry. Nuwellis vs. Its Competitors Meihua International Medical Technologies WORK Medical Technology Group LTD Ordinary Shares SeaStar Medical Biotricity DIH Holding US Intelligent Bio Solutions PAVmed STRATA Skin Sciences Innovative Eyewear Co-Diagnostics Meihua International Medical Technologies (NASDAQ:MHUA) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, dividends, profitability, earnings, media sentiment, valuation and risk. Which has stronger valuation & earnings, MHUA or NUWE? Meihua International Medical Technologies has higher revenue and earnings than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeihua International Medical Technologies$96.91M0.10$11.62MN/AN/ANuwellis$8.79M0.15-$20.21M-$18.24-0.02 Which has more volatility & risk, MHUA or NUWE? Meihua International Medical Technologies has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Do analysts recommend MHUA or NUWE? Nuwellis has a consensus target price of $17.00, indicating a potential upside of 5,383.87%. Given Nuwellis' stronger consensus rating and higher probable upside, analysts clearly believe Nuwellis is more favorable than Meihua International Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Meihua International Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nuwellis 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is MHUA or NUWE more profitable? Meihua International Medical Technologies has a net margin of 0.00% compared to Nuwellis' net margin of -169.54%. Meihua International Medical Technologies' return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Meihua International Medical TechnologiesN/A N/A N/A Nuwellis -169.54%-28,159.25%-207.24% Do institutionals and insiders hold more shares of MHUA or NUWE? 1.2% of Meihua International Medical Technologies shares are owned by institutional investors. Comparatively, 3.1% of Nuwellis shares are owned by institutional investors. 66.6% of Meihua International Medical Technologies shares are owned by insiders. Comparatively, 1.6% of Nuwellis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to MHUA or NUWE? In the previous week, Nuwellis had 2 more articles in the media than Meihua International Medical Technologies. MarketBeat recorded 5 mentions for Nuwellis and 3 mentions for Meihua International Medical Technologies. Meihua International Medical Technologies' average media sentiment score of 1.42 beat Nuwellis' score of 0.37 indicating that Meihua International Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Meihua International Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nuwellis 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor MHUA or NUWE? Nuwellis received 23 more outperform votes than Meihua International Medical Technologies when rated by MarketBeat users. CompanyUnderperformOutperformMeihua International Medical TechnologiesN/AN/ANuwellisOutperform Votes2354.76% Underperform Votes1945.24% SummaryMeihua International Medical Technologies beats Nuwellis on 8 of the 15 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.36M$3.31B$5.61B$8.62BDividend YieldN/A1.75%5.28%4.17%P/E Ratio0.0018.7727.2119.96Price / Sales0.15203.96408.49157.63Price / CashN/A44.0938.2534.64Price / Book0.023.887.074.69Net Income-$20.21M$94.03M$3.23B$248.14M7 Day Performance-23.10%8.84%0.68%0.91%1 Month Performance-68.97%18.26%9.59%5.71%1 Year Performance-95.53%38.27%32.02%14.71% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis3.1054 of 5 stars$0.31-16.0%$17.00+5,383.9%-95.8%$1.36M$8.79M0.0070Gap UpHigh Trading VolumeMHUAMeihua International Medical Technologies1.7306 of 5 stars$0.50-5.7%N/A-50.0%$12.54M$96.91M0.00620Short Interest ↓WOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.83-7.0%N/AN/A$12.04M$11.51M0.00226Positive NewsGap DownICUSeaStar Medical0.3666 of 5 stars$1.15-2.5%N/A-66.8%$11.91M$428K-0.102Short Interest ↑BTCYBiotricityN/A$0.47-10.5%N/A-48.5%$11.82M$12.06M-0.4440Gap UpDHAIDIH Holding US0.9648 of 5 stars$0.25+7.6%N/A-91.3%$11.60M$64.47M-0.82N/APositive NewsGap DownINBSIntelligent Bio Solutions0.4886 of 5 stars$1.60+11.9%N/A-15.2%$11.06M$2.94M0.0010Positive NewsPAVMPAVmed3.8179 of 5 stars$0.60-1.7%$19.50+3,152.7%-35.4%$10.25M$1.99M-0.1490SSKNSTRATA Skin Sciences2.8719 of 5 stars$2.40-3.2%$6.00+150.0%-26.2%$10.01M$33.62M-0.90120Negative NewsShort Interest ↑LUCYInnovative Eyewear1.2332 of 5 stars$3.12flatN/A-73.6%$9.66M$1.71M-0.329Short Interest ↓CODXCo-Diagnostics4.1602 of 5 stars$0.28+8.6%$5.50+1,838.7%-78.8%$9.53M$3.71M-0.21100Short Interest ↑ Related Companies and Tools Related Companies MHUA Alternatives WOK Alternatives ICU Alternatives BTCY Alternatives DHAI Alternatives INBS Alternatives PAVM Alternatives SSKN Alternatives LUCY Alternatives CODX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.